Apellis Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Apellis Pharmaceuticals Inc
TickerAPLS
CIK #0001492422
CUSIP03753U106
SectorLife Sciences - Pharmaceutical Preparations
Address6400 Westwind Way Suite A, Crestwood, KY 40014
Source [EDGAR]
CIK Filing 2011 - 2025
[0001492422] 10-K
[0001492422] 10-Q
[0001492422] 3
[0001492422] 4
[0001492422] 5
[0001492422] 8-K
[0001492422] D
[0001492422] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Deep Track Capital LP Apellis Pharmaceuticals Inc [2025-05-16] 0.0
Morgan Stanley Apellis Pharmaceuticals Inc [2025-02-03] 0.0
Deep Track Capital LP Apellis Pharmaceuticals Inc [2024-11-22] 5.0
BlackRock Inc Apellis Pharmaceuticals Inc [2024-11-08] 5.1
BlackRock Inc Apellis Pharmaceuticals Inc [2024-10-18] 5.1
T Rowe Price Investment Management Inc Apellis Pharmaceuticals Inc [2024-02-14] 5.3
EcoR1 Capital LLC Apellis Pharmaceuticals Inc [2023-07-18] 5.4
T Rowe Price Investment Management Inc Apellis Pharmaceuticals Inc [2023-02-14] 5.3
Price T Rowe Associates Inc /MD/ Apellis Pharmaceuticals Inc [2022-02-14] 5.4
Avoro Capital Advisors LLC Apellis Pharmaceuticals Inc [2022-02-11] 8.9
Vanguard Group Inc Apellis Pharmaceuticals Inc [2021-02-10] 7.32
Wellington Management Group LLP Apellis Pharmaceuticals Inc [2020-01-28] 6.92
Morningside Venture Investments Ltd Apellis Pharmaceuticals Inc [2019-02-14] 20.6
BlackRock Inc Apellis Pharmaceuticals Inc [2019-02-08] 6.6
Morningside Venture Investments Ltd Apellis Pharmaceuticals Inc [2018-02-14] 22.6
Hillhouse Capital Management Ltd Apellis Pharmaceuticals Inc [2018-02-14] 7.01
venBio Global Strategic Fund II LP Apellis Pharmaceuticals Inc [2018-02-09] 7.1
Potentia Holdings LLC Apellis Pharmaceuticals Inc [2018-02-08] 7.6
Cormorant Asset Management LLC Apellis Pharmaceuticals Inc [2017-11-21] 2.81
Form 3/4/5 Filer 2011 - 2025
Apellis Pharmaceuticals, Inc.
Watson David O.
Francois Cedric
Chopas James George
Deschatelets Pascal
Baumal Caroline
DeLong Mark Jeffrey
Sullivan Timothy Eugene
Nicholson Nur
Boucher Kelley
Wheeler Craig A
Townsend Adam J.
Lewis Karen
Eisele Jeffrey
Walbert Keli
O'Brien Stephanie Monaghan
Machiels Alec
Fonteyne Paul R
Dunlop A. Sinclair
Chan Gerald
Scheibler Lukas
Brown Victoria L.
Grossi Federico
Morningside Venture Investments Ltd
Perry Nicole D
Lackner Thomas A.
Celona Lucia
Sadr Ahmad
Axon Steven
Hillhouse Investment Management Ltd
Cormorant Global Healthcare Master Fund, LP
Chen Bihua
Cormorant Global Healthcare GP, LLC
Cormorant Asset Management, LP
Gellert Michael E
venBio Global Strategic Fund II L.P.
AJU IB Investment Co., Ltd.
Potentia Holdings, LLC
Cormorant Private Healthcare Fund I LP
Form 13F Holdings
Firm Period DFND Voting Shares
Avoro Capital Advisors LLC [2025-06-30] SOLE 12,222,222 12,222,222
EcoR1 Capital LLC [2025-06-30] SOLE 11,895,808 11,895,808
Vanguard Group Inc [2025-06-30] SOLE 0 10,000,848
Morgan Stanley [2025-06-30] DFND 9,720,601 9,752,201
Wellington Management Group LLP [2025-06-30] DFND 0 8,976,962
Deep Track Capital LP [2025-06-30] SOLE 7,000,000 7,000,000
BlackRock, Inc. [2025-06-30] SOLE 6,089,984 6,403,955
AQR Capital Management LLC [2025-06-30] DFND 5,534,323 5,838,045
UBS Group AG [2025-06-30] DFND 4,716,405 4,735,311
State Street Corp [2025-06-30] DFND 3,284,654 3,562,721
Suvretta Capital Management LLC [2025-06-30] SOLE 2,878,000 2,878,000
Marshall Wace LLP [2025-06-30] OTR 0 2,704,837
Siren, L.L.C. [2025-06-30] DFND 2,578,396 2,578,396
Jennison Associates LLC [2025-06-30] DFND 2,481,588 2,482,368
Bank of America Corp /DE/ [2025-06-30] DFND 84,768 2,426,628
Norges Bank [2025-06-30] SOLE 2,367,224 2,367,224
Geode Capital Management LLC [2025-06-30] DFND 1,995,271 1,995,271
Amundi [2025-06-30] DFND 1,604,105 1,604,105
OrbiMed Advisors LLC [2025-06-30] DFND 161,600 1,532,300
Deutsche Bank AG [2025-06-30] DFND 1,355,176 1,482,158
Polar Capital Holdings Plc [2025-06-30] DFND 1,352,175 1,352,175
BNP Paribas Financial Markets [2025-06-30] DFND 0 1,295,659
Braidwell LP [2025-06-30] SOLE 1,121,034 1,121,034
Wells Fargo & Company/MN [2025-06-30] DFND 1,041,473 1,043,655
Susquehanna International Group LLP [2025-06-30] OTR 328,726 1,011,426
Logos Global Management LP [2025-06-30] SOLE 1,000,000 1,000,000
Charles Schwab Investment Management Inc [2025-06-30] SOLE 989,143 989,143
Octagon Capital Advisors LP [2025-06-30] SOLE 903,500 903,500
Camber Capital Management LP [2025-06-30] SOLE 850,000 850,000
Ameriprise Financial Inc [2025-06-30] DFND 0 750,161
Prev | Page 2 | Next
Terms | Privacy | Guide
tony@aum13f.com